Psilocybin for Treatment-Resistant Major Depression - Results From an Academic Phase 2b Randomized-Controlled Trial

被引：0
|
作者：
Mertens, Lea Julia [1 ]
机构：
[1] Heidelberg Univ, Cent Inst Mental Hlth, Mannheim, Germany
来源：
NEUROPSYCHOPHARMACOLOGY | 2024年 / 49卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
10.2
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [41] Adjunctive Simvastatin for Treatment-Resistant Depression: A 12-Week, Multicentre, Randomized Controlled Trial
    Husain, Ishrat
    Chaudhry, Imran
    Khoso, Ameer
    Kiran, Tayyeba
    Khan, Nawaz
    Hodsoll, John
    Husain, Mohammed Omair
    Naqvi, Haider
    Minhas, Fareed
    Meyer, Jeffrey H.
    Ansari, Moin
    Mulsant, Benoit H.
    Husain, Nusrat
    Young, Allan H.
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 203 - 204
  • [42] A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression
    Fitzgerald, PB
    Benitez, J
    de Castella, A
    Daskalakis, ZJ
    Brown, TL
    Kulkarni, J
    AMERICAN JOURNAL OF PSYCHIATRY, 2006, 163 (01): : 88 - 94
  • [43] Rapid neuroplasticity changes and response to intravenous ketamine: a randomized controlled trial in treatment-resistant depression
    Jared Kopelman
    Timothy A. Keller
    Benjamin Panny
    Angela Griffo
    Michelle Degutis
    Crystal Spotts
    Nicolas Cruz
    Elizabeth Bell
    Kevin Do-Nguyen
    Meredith L. Wallace
    Sanjay J. Mathew
    Robert H. Howland
    Rebecca B. Price
    Translational Psychiatry, 13
  • [44] A Randomized, Placebo-Controlled Adjunctive Trial of Riluzole in Treatment-Resistant Major Depressive Disorder
    Mathew, Sanjay
    Fava, Maurizio
    Guerguieva, Ralitza
    Sanacora, Gerard
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S161 - S162
  • [45] Rapid neuroplasticity changes and response to intravenous ketamine: a randomized controlled trial in treatment-resistant depression
    Kopelman, Jared
    Keller, Timothy A.
    Panny, Benjamin
    Griffo, Angela
    Degutis, Michelle
    Spotts, Crystal
    Cruz, Nicolas
    Bell, Elizabeth
    Do-Nguyen, Kevin
    Wallace, Meredith L.
    Mathew, Sanjay J.
    Howland, Robert H.
    Price, Rebecca B.
    TRANSLATIONAL PSYCHIATRY, 2023, 13 (01)
  • [46] EFFECTS OF KETAMINE ON EXPLICIT AND IMPLICIT SUICIDAL COGNITION: A RANDOMIZED CONTROLLED TRIAL IN TREATMENT-RESISTANT DEPRESSION
    Price, Rebecca B.
    Iosifescu, Dan V.
    Murrough, James W.
    Chang, Lee C.
    Al Jurdi, Rayan K.
    Iqbal, Syed Z.
    Soleimani, Laili
    Charney, Dennis S.
    Foulkes, Alexandra L.
    Mathew, Sanjay J.
    DEPRESSION AND ANXIETY, 2014, 31 (04) : 335 - 343
  • [47] Pilot Randomized Controlled Trial of Titrated Subcutaneous Ketamine in Older Patients with Treatment-Resistant Depression
    George, Duncan
    Galvez, Veronica
    Martin, Donel
    Kumar, Divya
    Leyden, John
    Hadzi-Pavlovic, Dusan
    Harper, Simon
    Brodaty, Henry
    Glue, Paul
    Taylor, Rohan
    Mitchell, Philip B.
    Loo, Colleen K.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2017, 25 (11): : 1199 - 1209
  • [48] Double cone coil rTMS efficacy for treatment-resistant depression: A prospective randomized controlled trial
    Tastevin, Maud
    Baumstarck, Karine
    Groppi, Florence
    Cermolacce, Michel
    Lagrange, Guillaume
    Lancon, Christophe
    Richieri, Raphaelle
    BRAIN STIMULATION, 2020, 13 (01) : 256 - 258
  • [49] On blinding and suicide risk in a recent trial of psilocybin-assisted therapy for treatment-resistant depression
    Gukasyan, Natalie
    MED, 2023, 4 (01): : 8 - 9
  • [50] Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial
    Galvez, Veronica
    Li, Adrienne
    Huggins, Christina
    Glue, Paul
    Martin, Donel
    Somogyi, Andrew A.
    Alonzo, Angelo
    Rodgers, Anthony
    Mitchell, Philip B.
    Loo, Colleen K.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2018, 32 (04) : 397 - 407
12345